Threadline News
SearchGet the morning brief

Form 8-K, current report

Matinas BioPharma Holdings, Inc., 8-K filed 2026-09-04

Published 4 Sep 2026 · retrieved 8 Sep 2026, 02:30 EDT · version 1Official source

The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.

Filing record

1

8-K filed with the Securities and Exchange Commission by Matinas BioPharma Holdings, Inc. (CIK 0001582554) on 2026-09-04.

2

Accession number 0001493152-26-041577. EDGAR reports the filing package as 238 KB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/1582554/000149315226041577/0001493152-26-041577-index.htm.

Items reported on the cover

1

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

2

Item 8.01: Other Events

3

Item 9.01: Financial Statements and Exhibits